Asia Pacific Blood Glucose Monitoring Market Latest Study Focuses on Current, Future Innovations and Top Key Vendors | Forecast 2030
Asia Pacific Blood Glucose Monitoring Market Highlights
Several
devices for testing the glucose level in the blood are available in the market
such as invasive glucose monitoring devices, continuous glucose monitoring
devices (CGM), and flash glucose monitoring devices. These devices are designed
according to the type of diabetes, which help to identify the blood glucose
level within the specified target range and hence help you to track your diet
accordingly. Growing awareness regarding the devices in developing countries
has fuelled the demand for these devices in Asia Pacific region.
According
to the American Diabetes Association, the blood glucose levels for an adult
without diabetes is below 100 mg/dl before meals and fasting and is less than
140 mg/dl two hours after a meal.
Diabetes
is one of the leading causes of premature death and disability. It can be
managed effectively if it diagnosed at early stage. However, if left untreated,
it can lead to various complications such as heart disease, stroke, kidney
damage, and nerve damage.
The Asia Pacific Blood Glucose Monitoring market is expected to reach USD 2,041.6 Million by 2030
at CAGR 13.6% during the forecast period 2022-2030
Regional
Analysis
China
dominates the Asia Pacific blood glucose monitoring market owing to
well-developed technology, increasing patient population with diabetes, high
health care spending, and increasing government support for research & development.
According to WHO, 110 million people have with diabetes in China.
India
is the second leading country having many diabetic patient populations in Asia
Pacific. According to International Diabetes Federation, over 69.1 million
people in 2015 had diabetes in India. Diabetes is one of the major diseases in
India. Over 50 million people have diabetes in India.
Furthermore,
countries such as Japan, Australia, and the Republic of Korea are showing a
considerable growth in the blood glucose monitoring market.
However,
increasing awareness, and development of the treatment technology is fuelling
the demand for the blood glucose monitoring devices in countries like South Korea and India.
Segmentation
The Asia
Pacific blood glucose monitoring devices market is segmented based on product
type, application, and end user.
Based
on the product type, it is segmented into invasive glucose monitoring devices,
continuous glucose monitoring devices (CGM), flash glucose monitoring devices,
and self-monitoring
blood glucose meter.
Based
on the application, it is segmented into type 1 diabetes, type 2 diabetes, and others.
Based
on the end user, it is segmented into diagnostic centres, hospitals, clinics,
research centres, and home care diagnostics.
Asia Pacific Blood Glucose Monitoring Market
Players
Asia Pacific blood glucose monitoring market report players are Abbott Laboratories, Arkay, Inc., Bayer
Healthcare AG, F. Hoffmann-La Roche, Goldsite Diagnostics Inc., GlySure Ltd,
Sphere Medical, Dexcom, Inc., and LifeScan.
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment